Top Markets
#1 OpenVPP OpenVPP +13,448.23%
#2 BugsCoin BugsCoin +49.61%
#3 GENIUS AI GENIUS AI +48.16%
#4 TAC TAC +34.76%
#5 Solidus Ai Tech Solidus Ai Tech +30.89%
#6 Zerebro Zerebro +28.49%
#7 Avici Avici +24.70%
#8 Swarms Swarms +19.08%
#9 Resolv RLP Resolv RLP +17.22%
#10 AI Rig Complex AI Rig Complex +12.79%
Coin of the day
OpenVPP OpenVPP
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hikal Limited Hikal Limited

Hikal Limited

HIKAL
Classifica tra le azioni #10836
Hikal Limited, together with its subsidiaries, manufactures and sells various... Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Prezzo delle azioni
$2.09
Capitalizzazione di mercato
$257.37M
Variazione (1 giorno)
0.76%
Variazione (1 anno)
-55.56%
Paese
IN
Scambia Hikal Limited (HIKAL)

Categoria

Healthcare
Rapporto P/B per Hikal Limited (HIKAL)
Rapporto P/B al April 2026 TTM: 1.94
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Hikal Limited, il rapporto P/B attuale (TTM) è 1.94. Alla fine del 2024, era pari a 2.86.
Storico del rapporto P/B per Hikal Limited da 2005 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 1.94 -50.55%
2025 3.92 36.98%
2024 2.86 -6.57%
2023 3.06 -34.04%
2022 4.64 144.93%
2021 1.90 80.29%
2020 1.05 -64.51%
2019 2.96 17.17%
2018 2.53 -12.92%
2017 2.90 69.75%
2016 1.71 -20.87%
2015 2.16 41.18%
2014 1.53 2.58%
2013 1.49 43.92%
2012 1.04 -12.59%
2011 1.19 -24.95%
2010 1.58 125.80%
2009 0.70 -82.30%
2008 3.96 21.30%
2007 3.26 -38.67%
2006 5.32 -1.71%
2005 5.41 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 3.128 61.38%
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 1.7723 -8.56%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 1.1696 -39.66%
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 15.9323 721.97%
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.1551 165.96%
IN